Skip to main content
Acta Crystallographica Section F: Structural Biology and Crystallization Communications logoLink to Acta Crystallographica Section F: Structural Biology and Crystallization Communications
. 2012 Aug 30;68(Pt 9):1034–1039. doi: 10.1107/S1744309112032538

Crystallization and preliminary crystal structure analysis of the ligand-binding domain of PqsR (MvfR), the Pseudomonas quinolone signal (PQS) responsive quorum-sensing transcription factor of Pseudomonas aeruginosa

Ningna Xu a,, Shen Yu b,, Sébastien Moniot a, Michael Weyand a, Wulf Blankenfeldt a,*,
PMCID: PMC3433192  PMID: 22949189

The ligand-binding domain of the transcription factor PqsR from P. aeruginosa has been crystallized and initial phases have been obtained using SAD data from seleno-l-methionine-labelled crystals.

Keywords: LysR, LTTR, quorum sensing, virulence, infectious diseases, signal transduction

Abstract

The opportunistic bacterial pathogen Pseudomonas aeruginosa employs three transcriptional regulators, LasR, RhlR and PqsR, to control the transcription of a large subset of its genes in a cell-density-dependent process known as quorum sensing. Here, the recombinant production, crystallization and structure solution of the ligand-binding domain of PqsR (MvfR), the LysR-type transcription factor that responds to the Pseudomonas quinolone signal (PQS), a quinolone-based quorum-sensing signal that is unique to P. aeruginosa and possibly a small number of other bacteria, is reported. PqsR regulates the expression of many virulence genes and may therefore be an interesting drug target. The ligand-binding domain (residues 91–319) was produced as a fusion with SUMO, and hexagonal-shaped crystals of purified PqsR_91–319 were obtained using the vapour-diffusion method. Crystallization in the presence of a PQS precursor allowed data collection to 3.25 Å resolution on a synchrotron beamline, and initial phases have been obtained using single-wavelength anomalous diffraction data from seleno-l-methionine-labelled crystals, revealing the space group to be P6522, with unit-cell parameters a = b = 116–120, c = 115–117 Å.

1. Introduction  

In order to effectively colonize a habitat, microorganisms need to coordinate their cellular activities not only to environmental cues but also to their own cell density. This is achieved through ‘quorum sensing’ (QS), a process that relies on self-synthesized diffusible small molecules called ‘autoinducers’ (AIs) that can cross the cell membrane in both directions and activate certain transcription factors (TFs) once a threshold concentration has been reached. Because AI-activated TFs also induce the transcription of AI synthase genes, a positive-feedback loop is generated that shifts metabolic energy from replication to the generation of molecules such as virulence factors that help the microorganism to further establish itself in the given environment (Antunes et al., 2010). It is obvious that components of the QS machinery are potential drug targets in infectious diseases since their inhibition may reduce virulence and make the infectious agent more susceptible to the immune system of the host or to drugs (Njoroge & Sperandio, 2009).

Pseudomonas aeruginosa is a Gram-negative bacterium that causes a large number of opportunistic infections, especially in hospitals and in patients with cystic fibrosis, where it leads to chronic infection of the lungs and is the main cause of early mortality. P. aeruginosa infections are difficult to treat owing to the fact that the bacterium encodes a large number of efflux pumps for xenobiotics and forms robust biofilms in which it cannot easily be reached by pharmaceuticals (Høiby et al., 2010). In addition, it produces a large arsenal of virulence factors that protect it against the immune system of the host and lead to tissue damage. Biofilm generation and the production of virulence factors are under QS control, which in P. aeruginosa involves three different AI/TF circuits that are arranged in a hierarchical manner and are interwoven into a network that also integrates other signals (Schuster & Greenberg, 2006). Of the three QS TFs, the LuxR-type family members LasR and RhlR are activated by the N-acyl-homoserine lactones (AHLs) N-(3-oxododecanoyl)-l-homoserine lactone (C12-AHL) and N-butyryl-l-homoserine lactone (C4-AHL), respectively. A third autoinducer, the ‘Pseudomonas quinolone signal’ 2-heptyl-3-hydroxy-4-quinolone (PQS) has recently been discovered (Pesci et al., 1999). It binds and activates a TF originally named ‘multiple virulence-factor regulator’ MvfR (Cao et al., 2001), which is now more often referred to as PqsR. PqsR contains 332 amino acids and belongs to the LysR family of TFs (also called LTTRs). These proteins possess a ligand-binding domain (approximately residues 90–320 in PqsR) that is connected via a long α-helix to a DNA-binding helix–turn–helix motif (residues 5–65 in PqsR). They associate into tetramers that are best described as dimers of dimers in which the initial dimerization is achieved by the interaction of two ligand-binding domains and the second dimerization occurs through antiparallel coiled-coil interactions along the α-­helices that connect the ligand-binding and DNA-binding domains (Muraoka et al., 2003; Zhou et al., 2010). As a consequence, LTTRs contain four DNA-binding domains that recognize approximately 60 bp of DNA. In the case of PqsR, AI binding triggers transcription of the pqsA–E and phnAB operons, which are both required for PQS biosynthesis (Gallagher et al., 2002). Localization and expression studies have suggested that PqsR is associated with the inner membrane and that it is deactivated by cleavage with translocation of an N-­terminal fragment in the stationary phase (Cao et al., 2001).

The PQS system seems to be unique to P. aeruginosa and a handful of related species (Diggle et al., 2006). It acts in an intermediate fashion within the quorum-sensing network of P. aeruginosa by being activated by the las system and itself upregulating the rhl-regulated virulence factors through a mechanism the details of which are not yet fully understood (Fig. 1). Apparently, this mechanism involves the ‘PQS-response protein’ PqsE, a member of the metallo-β-lactamase family co-transcribed and therefore upregulated together with other enzymes required for PQS biosynthesis in a PqsR-dependent manner. The substrate of PqsE remains to be determined (Yu et al., 2009), but it has been shown in three independent studies that both PqsE and the cognate N-acyl-homoserine lactone are required for RhlR-dependent virulence-factor production (Farrow et al., 2008; Rampioni et al., 2010; Hazan et al., 2010). The transcription factor PqsR may therefore be an attractive drug target for new agents against P. aeruginosa, since it is almost unique to this pathogen and is required for the production of the indispensable factor PqsE.

Figure 1.

Figure 1

Importance of PqsR in a simplified diagram of the P. aeruginosa quorum-sensing cascade. (1) The PQS system itself is activated by the LasR–N-(3-oxododecanoyl)-l-homoserine lactone (C12-AHL) complex. (2) Binding of PQS to PqsR leads to autoinduction of the pqs operon. (3) PqsE enhances the activation of virulence genes (4) by RhlR–N-butyryl-l-homoserine lactone (C4-AHL) through an unknown mechanism.

A number of studies have investigated transcriptional regulation by PqsR and it has been demonstrated that it can also be activated by the PQS precursor 4-hydroxy-2-heptylquinolone (HHQ), albeit to a lesser extent than by PQS (Xiao et al., 2006). Farnesol has been found to inhibit PqsR, which was attributed to the induction of a non­productive binding mode to the promotor sequence (Cugini et al., 2007). Recently, it has been demonstrated that 2-aminoaceto­phenone, a volatile substance that gives P. aeruginosa cultures their typical smell, downregulates PqsR-dependent virulence processes (Kesarwani et al., 2011) and the first synthetic inhibitors of PQS signalling have also been described (Lesic et al., 2007; Lu et al., 2012).

In order to improve opportunities for the design of inhibitors that block PQS signalling, structural insight into PqsR is highly sought. Very recently, Kefala and coworkers reported tetragonal crystals of a 242-residue C-terminal fragment that diffracted to 5 Å resolution (Kefala et al., 2012). Here, we describe a hexagonal crystal form that is adopted by both the unlabelled and seleno-l-methionine-labelled ligand-binding domain of PqsR (residues 91–319) and that diffracts to 3.25 Å resolution.

2. Materials and methods  

2.1. Cloning, expression and protein purification  

Genomic DNA of P. aeruginosa strain PAO1 and sequence-specific DNA primers were used to amplify different stretches of the pqsR gene (Pseudomonas Genome Database entry PA1003; Winsor et al., 2010). These PCR products were used for generation of expression plasmids using the services of the Dortmund Protein Facility (http://www.mpi-dortmund.mpg.de/misc/dpf/index.htm), which employs a recombination-based protocol (Oliner et al., 1993; Li & Elledge, 2007). Correct integration into the plasmid backbones was confirmed by DNA sequencing. Protease-cleavable N-terminal His6 tags with or without a downstream SUMO (small ubiquitin-related modifier) solubility enhancer fused to different fragments of PqsR (full length or fragments of the ligand-binding domain) were tested for expression and solubility in Escherichia coli under different expression conditions (IPTG induction at 293 or 310 K; autoinduction at 298 K). Only the SUMO fusions gave soluble proteins, but several, including the full-length construct, precipitated during the course of tag removal with SUMO protease. Therefore, subsequent work focused on a fragment consisting of residues 91–319, which comprises the ligand-binding domain of PqsR. The forward DNA primer used for amplification of this fragment was 5′-GCGAACAGATCGGTGGT­GGTCCGCGCAATCTCCGG-3′ and the reverse primer was 5′-CGTGTCTAGAAAGCTTCAGCCTGAGCGGCGCTGC-3′. The resulting expression plasmid pOPIN-His-SUMO-PqsR_91-319 encodes a fusion protein consisting of an N-terminal His6 tag linked to residues 2–98 of Saccharomyces cerevisiae ubiquitin-like protein SMT3 (SUMO; UniProt entry Q12306) followed by PqsR_91-319 (full sequence His6-SUMO-PqsR_91–319: mgsshhhhhhgSDSEVNQEAKPEVKPEVKPETHINLKVSDGSSEIFFKIKKTTPLRRLMEAFAKRQGKMEDSLRFLYDGIRIQADQTPEDLDMEDNDIIEAHREQIGG|GPRNLRVLLDTAIPPSFCDTVSSVLLDDFNMVSLIRTSPADSLATIKQDNAEIDIAITIDEELKISRFNQCVLGYTKAFVVAHPQHPLCNASLHSIASLANYRQISLGSRSGQHSNLLRPVSDKVLFVENFDDMLRLVEAGVGWGIAPHYFVEERLRNGTLAVLSELYEPGGIDTKVYCYYNTALESERSFLRFLESARQRLRELGRQRFDDAPAWQPSIVETAQRRSG, where lower-case letters indicate the affinity tag, italic letters indicate SUMO and | indicates the SUMO protease cut site).

The plasmid was transformed into E. coli Rosetta2 pLysS cells and the cells were grown to an OD600 of 0.7 at 310 K in Terrific Broth supplemented with 100 µg ml−1 ampicillin and 34 µg ml−1 chloramphenicol. The temperature was then reduced to 293 K and protein expression was induced with 0.5 mM IPTG for 16 h. The cells were then harvested by centrifugation, resuspended in buffer A (50 mM Na2HPO4, 300 mM NaCl pH 8.0) containing 1 mM PMSF and lysed by passage through a Microfluidizer (Microfluidics) three times. Insoluble matter was separated by centrifugation at 40 000g for 1 h and the resulting supernatant was filtered through a 0.2 µm filter before loading onto a HiTrap Chelating HP column (GE Healthcare) charged with 100 mM NiSO4. The column was then washed with buffer A until the OD280 was constant. Nonspecifically bound proteins were removed by washing with buffer A containing 5% buffer B (buffer A supplemented with 500 mM imidazole) before developing the column with a gradient to 100% buffer B. PqsR_91–319 eluted at 25–30% buffer B. Fractions containing pure His6-SUMO-PqsR_91–319 were identified by SDS–PAGE and pooled. Protein concentrations were measured by UV absorption (calculated ∊280 = 27.640 mol−1 cm−1) and 1 mg recombinant SUMO protease was added to 100 mg pooled protein to remove all of the residues of the His6-SUMO tag from PqsR_91–319. Cleavage was allowed to proceed in a dialysis bag (cutoff 10 kDa) equilibrated against 50 mM HEPES, 150 mM NaCl pH 8.0 overnight at 277 K. The precipitate was sedimented by centrifugation and uncleaved protein was removed by passing the supernatant over a HiTrap Chelating HP column again. The flowthrough was collected, concentrated by ultrafiltration (Falcon UltraCentrifugal filter units, 10 kDa cutoff) and then applied to size-exclusion chromatography on a Superdex 75 26/60 column (GE Healthcare) equilibrated with 20 mM Tris–HCl, 150 mM NaCl, 5 mM β-mercaptoethanol pH 8.0. PqsR_91–319 eluted with approximately the same retention time as a 44 kDa molecular-weight standard (Supplementary Fig. S11), which is indicative of a homodimer (the calculated molecular weight of PqsR_91–319 is 52.1 kDa). The pure protein was concentrated to approximately 15 mg ml−1 in the same buffer and flash-cooled in liquid nitrogen for storage at 193 K if not used immediately, since no differences in crystallization behaviour were noted between fresh and cooled protein samples.

Seleno-l-methionine labelling was achieved by suppression of methionine biosynthesis (Doublié, 1997) in SeMet minimal medium (Guerrero et al., 2001); the labelled protein was purified using the same strategy as that used for the native protein.

2.2. Crystallization, data collection and structure solution  

Initial crystallization conditions of tag-removed PqsR_91–319 were identified by the sitting-drop vapour-diffusion method using JCSG Core Suites I–IV (Qiagen) and drops consisting of 150 nl protein solution and 150 nl mother liquor prepared using a nanodispensing robot (Phoenix, Art Robbins Instruments). The protein was screened at three different concentrations (7.5, 10 and 15 mg ml−1) with or without pre-incubation with 4-hydroxy-2-heptylquinoline (HHQ), which was added to the protein solution to a final concentration of 5 mM from a 100 mM stock in DMSO. All crystallization experiments were performed at room temperature. Diamond-shaped crystals appeared using several precipitants, the compositions of which were subsequently optimized in 1 µl + 1 µl hanging drops equilibrated against 500 µl reservoir to generate larger crystals. The final precipitant in the case of native PqsR_91–319 in the presence of HHQ consisted of 0.2 M MgCl2, 0.1 M Tris–HCl pH 8.4–8.6, 45%(v/v) ethylene glycol and the protein was employed at 15 mg ml−1. The seleno-l-methionine-labelled protein gave crystals with a similar morphology, but the reservoir used for the data reported here consisted of 0.2 M LiCl, 0.1 M sodium citrate pH 5.6–5.8, 14–16%(v/v) ethanol. These crystals only appeared in the absence of HHQ.

Prior to data collection, the crystals were flash-cooled by plunging crystals mounted in nylon loops into liquid nitrogen. No cryoprotection was required for the native protein cocrystallized with HHQ, while the seleno-l-methionine derivative was briefly washed in mother liquor supplemented with 15%(v/v) glycerol. Diffraction data were collected using a Rayonics MX-225 CCD detector on beamline BL 14.1 of the BESSY II synchrotron (Helmholtz Zentrum Berlin, Germany; Mueller et al., 2012). A native data set was collected as 220 non-overlapping 0.5° oscillation images at a wavelength of 0.92526 Å (13.4 keV). For the seleno-l-methionine derivative, the X-ray energy was set to the approximate value of the Se K edge (12.659 keV) and single-wavelength anomalous diffraction (SAD) data were collected as 720 non-overlapping 1° frames. A fluorescence scan was not performed. Both data sets reported in Table 1 were indexed and integrated with XDS (Kabsch, 2010) and scaled with SCALA (Evans, 2006) from the CCP4 package (Winn et al., 2011) using default parameter settings.

Table 1. Data-collection statistics.

Values in parentheses are for the highest resolution shell. Both data sets were collected from a single crystal on beamline BL14.1 of the BESSY II synchrotron (Helmholtz Zentrum Berlin, Germany).

Data set Se-SAD Native
Wavelength (Å) 0.97935 0.92526
Resolution range (Å) 48–3.40 (3.58–3.40) 46–3.25 (3.43–3.25)
Space group P6522 P6522
Unit-cell parameters (Å) a = b = 120.9, c = 114.6 a = b = 116.9, c = 117.4
Mosaicity (°) 0.157 0.161
Total No. of measured reflections 609714 (88480) 101880 (14797)
Unique reflections 7240 (1012) 7907 (1106)
Multiplicity 47.3 (47.4) 12.9 (13.4)
Mean I/σ(I) 25.0 (2.2) 19.2 (2.1)
Completeness (%) 100 (100) 99.9 (100)
R merge § (%) 25.5 (383.5) 10.0 (153.8)
R p.i.m. (%) 3.8 (56.3) 2.9 (43.0)
Optical resolution†† (Å) 2.56 2.44
Molecules per asymmetric unit 1 1
Matthews coefficient (Å3 Da−1) 4.72 4.52
Solvent content (%) 73.9 72.8

Friedel mates were treated as separate reflections.

Mosaicity values are as reported by XDS (Kabsch, 2010).

§

R merge = Inline graphic Inline graphic, where I i(hkl) is the intensity of the ith observation of the reflection with index hkl.

R p.i.m. = Inline graphic Inline graphic, where N is the number of observations of the reflection with index hkl (Weiss, 2001).

††

Optical resolution corresponds to the minimum distance of two peaks that are expected to be resolved in the electron-density map as calculated with SFCHECK (Vaguine et al., 1999).

Molecular replacement was attempted with BALBES (Long et al., 2008), and SAD data from the seleno-l-methionine-labelled crystal were analysed using the AutoSol routine of PHENIX (Adams et al., 2010). A sequence search with BLAST (Altschul et al., 1990) and structure prediction with PHYRE (Kelley & Sternberg, 2009) identified PDB entry 3fd3 (Midwest Center for Structural Genomics, unpublished work) as the LTTR structure that was most similar to PqsR_91–319, and MOLREP (Vagin & Teplyakov, 2010) was used to place this model into the SAD electron-density map. For crystal-packing analysis, the smaller domain of PDB entry 3fd3 was adjusted by hand using Coot (Emsley et al., 2010). Phasing of the native data applied a simple mask of this model constructed with NCSMASK followed by multi-crystal averaging with DMMULTI (Winn et al., 2011). Further density improvement resulted from application of the ‘phase and build’ option in PHENIX (Adams et al., 2010).

3. Results  

PqsR is an important regulator of virulence in the human opportunistic pathogen P. aeruginosa and knowledge of its three-dimensional structure could significantly boost existing efforts towards inhibitor development (Cugini et al., 2007; Lesic et al., 2007; Kesarwani et al., 2011; Lu et al., 2012). In order to obtain sufficient amounts of protein for structural studies, we tested approximately 30 different PqsR fragment constructs for soluble expression in E. coli. Only fusion proteins bearing an N-terminal His6-SUMO tag were soluble, including full-length PqsR, which however precipitated after tag removal with SUMO protease. It was therefore decided to focus on PqsR_91–319, which was predicted to contain the ligand-binding domain without a C-terminal structural element (residues 320–332) that is unique to PqsR. As expected, the protein eluted as a homodimer in the final gel filtration; the overall yield was 15 mg PqsR_91–319 from 1 l cell culture. Seleno-l-methionine labelling was readily achieved by suppression of methionine biosynthesis, but required a SeMet minimal medium developed by Guerrero et al. (2001); labelling was not successful in M9 or LeMaster media.

Several initial crystallization conditions were identified quickly, but the same diamond-shaped crystal morphology was always observed despite relatively large variations in the precipitant compositions. Careful optimization led to the conditions indicated in §2.2. Interestingly, while addition of HHQ improved the appearance of crystals of the native protein, no crystals could be obtained when this ligand was included in crystallization of the seleno-l-methionine-labelled protein. PQS was also tested, but was not soluble under the conditions tested. With optimized precipitants, crystals appeared after 6 d and grew to dimensions of approximately 200 × 150 × 50 µm (Fig. 2).

Figure 2.

Figure 2

Crystals of PqsR_91–319 grown in the presence of HHQ.

Despite their perfect morphology, labelled and unlabelled crystals diffracted only weakly using a sealed-tube X-ray home source. This was not a consequence of the cryocooling procedure as capillary-mounted crystals at room temperature showed similar diffraction. Even at the synchrotron the maximum resolution that could be obtained was 3.25 Å in the case of native PqsR_91–319. Another problem was the split appearance of the reflections (Fig. 3 a), which could be slightly improved by three rounds of 6 s freeze–thaw annealing of the worst (Supplementary Fig. S21) but not the best crystals, which are reported in Table 1. While the data could satisfyingly be indexed, integrated and merged in Laue class 6/mmm, spurious diffraction on the l axis (Fig. 3 b) hindered determination of the correct space group(s). However, the unit-cell parameters (a = b = 116.9, c = 117.4 Å for the native crystal and a = b = 120.1, c = 114.6 Å for the seleno-l-methionine derivative) suggested the presence of two protein chains in the asymmetric units at this stage.

Figure 3.

Figure 3

(a) The crystals shown in Fig. 2 typically showed split reflections. (b) Spurious diffraction misleads space-group determination. The pseudo-precession image was generated with HKLVIEW (Winn et al., 2011).

Significant effort was required to extend analyses of these crystals beyond this primitive state. Molecular replacement was not successful, despite a large number of structures related to PqsR_91–319 being available in the PDB and exhaustive attempts testing monomeric and dimeric as well as sequence-edited models using the molecular-replacement engine BALBES (Long et al., 2008). A breakthrough was achieved when initial phases to 3.7 Å resolution were obtained using SAD data from a seleno-l-methionine derivative with PHENIX in the AutoSol mode (Adams et al., 2010). The software located the four anomalous scatterers expected for the initially anticipated dimer. Initial phasing led to an overall FOM of 0.231, which increased to 0.778 after density modification and also revealed the correct space group to be P6522, since only this enantiomorph resulted in connected electron density with protein-like features. In particular, the electron density showed the presence of a five-stranded β-sheet, which is a hallmark of the ligand-binding domain of LysR-type transcription factors (Fig. 4 a). It was also possible to position the structure of a related protein (PDB entry 3fd3; Midwest Center for Structural Genomics, unpublished work) in this electron density, thereby strongly suggesting that the asymmetric unit contains only one protein chain, not the two that were initially expected from the unit-cell parameters. This also agrees with the finding that no noncrystallographic twofold axes could be detected by self-rotation search (Supplementary Fig. S31). Furthermore, the correspondingly high solvent content (73%; V M = 4.5 Å3 Da−1) is consistent with the relatively low resolution that was obtained (Kantardjieff & Rupp, 2003). Crystallographic symmetry thus generates the biological dimer of PqsR_91–319 and the packing produces solvent-filled channels along the c axis of the unit cell with an approximate diameter of 75 Å (Fig. 4 b).

Figure 4.

Figure 4

(a) Experimental electron density after density modification, revealing a five-stranded β-sheet typical of LTTRs. (b) P6522 crystal packing of PqsR_91–319 visualized by placing a related structure (PDB entry 3fd3; Midwest Center for Structural Genomics, unpublished work) into the electron density. This figure was generated with PyMOL (Schrödinger LLC).

In order to transfer and extend the phases in the higher resolution native data set, we used cross-crystal averaging with DMMULTI (Winn et al., 2011) and density modification through automatic model building in PHENIX (Adams et al., 2010). This significantly improved the electron-density map such that the positions of the side chains became visible in many places. However, the automatically generated models are strongly fragmented and need to be completed by hand, which is time-consuming owing to the low quality of the electron density in some regions of the molecule. As a result, significant effort will also be invested in improving the current crystals and searching for new and better diffracting crystals.

Acknowledgments

We thank the Dortmund Protein Facility for generating expression constructs and Susanne Häussler and Michael Mohr for synthetic HHQ and PQS. Anne Richter and Felix Brauer are acknowledged for practical assistance. Synchrotron diffraction data were collected by members of the X-ray communities at the Max Planck Institute of Molecular Physiology Dortmund (Germany) and the University of Bayreuth (Germany). We thank the Swiss Light Source (SLS; Paul Scherrer Institute Villigen, Switzerland) and BESSY II (Berlin, Germany) for providing us with access to their facilities.

Footnotes

1

Supplementary material has been deposited in the IUCr electronic archive (Reference: EN5509).

References

  1. Adams, P. D. et al. (2010). Acta Cryst. D66, 213–221.
  2. Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. (1990). J. Mol. Biol. 215, 403–410. [DOI] [PubMed]
  3. Antunes, L. C., Ferreira, R. B., Buckner, M. M. & Finlay, B. B. (2010). Microbiology, 156, 2271–2282. [DOI] [PubMed]
  4. Cao, H., Krishnan, G., Goumnerov, B., Tsongalis, J., Tompkins, R. & Rahme, L. G. (2001). Proc. Natl Acad. Sci. USA, 98, 14613–14618. [DOI] [PMC free article] [PubMed]
  5. Cugini, C., Calfee, M. W., Farrow, J. M. III, Morales, D. K., Pesci, E. C. & Hogan, D. A. (2007). Mol. Microbiol. 65, 896–906. [DOI] [PubMed]
  6. Diggle, S. P., Lumjiaktase, P., Dipilato, F., Winzer, K., Kunakorn, M., Barrett, D. A., Chhabra, S. R., Cámara, M. & Williams, P. (2006). Chem. Biol. 13, 701–710. [DOI] [PubMed]
  7. Doublié, S. (1997). Methods Enzymol. 276, 523–530. [PubMed]
  8. Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. (2010). Acta Cryst. D66, 486–501. [DOI] [PMC free article] [PubMed]
  9. Evans, P. (2006). Acta Cryst. D62, 72–82. [DOI] [PubMed]
  10. Farrow, J. M., Sund, Z. M., Ellison, M. L., Wade, D. S., Coleman, J. P. & Pesci, E. C. (2008). J. Bacteriol. 190, 7043–7051. [DOI] [PMC free article] [PubMed]
  11. Gallagher, L. A., McKnight, S. L., Kuznetsova, M. S., Pesci, E. C. & Manoil, C. (2002). J. Bacteriol. 184, 6472–6480. [DOI] [PMC free article] [PubMed]
  12. Guerrero, S. A., Hecht, H.-J., Hofmann, B., Biebl, H. & Singh, M. (2001). Appl. Microbiol. Biotechnol. 56, 718–723. [DOI] [PubMed]
  13. Hazan, R., He, J., Xiao, G., Dekimpe, V., Apidianakis, Y., Lesic, B., Astrakas, C., Déziel, E., Lépine, F. & Rahme, L. G. (2010). PLoS Pathog. 6, e1000810. [DOI] [PMC free article] [PubMed]
  14. Høiby, N., Bjarnsholt, T., Givskov, M., Molin, S. & Ciofu, O. (2010). Int. J. Antimicrob. Agents, 35, 322–332. [DOI] [PubMed]
  15. Kabsch, W. (2010). Acta Cryst. D66, 125–132. [DOI] [PMC free article] [PubMed]
  16. Kantardjieff, K. A. & Rupp, B. (2003). Protein Sci. 12, 1865–1871. [DOI] [PMC free article] [PubMed]
  17. Kefala, K., Kotsifaki, D., Providaki, M., Kapetaniou, E. G., Rahme, L. & Kokkinidis, M. (2012). Acta Cryst. F68, 695–697. [DOI] [PMC free article] [PubMed]
  18. Kelley, L. A. & Sternberg, M. J. (2009). Nature Protoc. 4, 363–371. [DOI] [PubMed]
  19. Kesarwani, M., Hazan, R., He, J., Que, Y. A., Que, Y., Apidianakis, Y., Lesic, B., Xiao, G., Dekimpe, V., Milot, S., Deziel, E., Lépine, F. & Rahme, L. G. (2011). PLoS Pathog. 7, e1002192. [DOI] [PMC free article] [PubMed]
  20. Lesic, B., Lépine, F., Déziel, E., Zhang, J., Zhang, Q., Padfield, K., Castonguay, M. H., Milot, S., Stachel, S., Tzika, A. A., Tompkins, R. G. & Rahme, L. G. (2007). PLoS Pathog. 3, 1229–1239. [DOI] [PMC free article] [PubMed]
  21. Li, M. Z. & Elledge, S. J. (2007). Nature Methods, 4, 251–256. [DOI] [PubMed]
  22. Long, F., Vagin, A. A., Young, P. & Murshudov, G. N. (2008). Acta Cryst. D64, 125–132. [DOI] [PMC free article] [PubMed]
  23. Lu, C., Kirsch, B., Zimmer, C., de Jong, J. C., Henn, C., Maurer, C. K., Müsken, M., Häussler, S., Steinbach, A. & Hartmann, R. W. (2012). Chem. Biol. 19, 381–390. [DOI] [PubMed]
  24. Mueller, U., Darowski, N., Fuchs, M. R., Förster, R., Hellmig, M., Paithankar, K. S., Pühringer, S., Steffien, M., Zocher, G. & Weiss, M. S. (2012). J. Synchrotron Rad. 19, 442–449. [DOI] [PMC free article] [PubMed]
  25. Muraoka, S., Okumura, R., Ogawa, N., Nonaka, T., Miyashita, K. & Senda, T. (2003). J. Mol. Biol. 328, 555–566. [DOI] [PubMed]
  26. Njoroge, J. & Sperandio, V. (2009). EMBO Mol. Med. 1, 201–210. [DOI] [PMC free article] [PubMed]
  27. Oliner, J. D., Kinzler, K. W. & Vogelstein, B. (1993). Nucleic Acids Res. 21, 5192–5197. [DOI] [PMC free article] [PubMed]
  28. Pesci, E. C., Milbank, J. B., Pearson, J. P., McKnight, S., Kende, A. S., Greenberg, E. P. & Iglewski, B. H. (1999). Proc. Natl Acad. Sci. USA, 96, 11229–11234. [DOI] [PMC free article] [PubMed]
  29. Rampioni, G., Pustelny, C., Fletcher, M. P., Wright, V. J., Bruce, M., Rumbaugh, K. P., Heeb, S., Cámara, M. & Williams, P. (2010). Environ. Microbiol. 12, 1659–1673. [DOI] [PMC free article] [PubMed]
  30. Schuster, M. & Greenberg, E. P. (2006). Int. J. Med. Microbiol. 296, 73–81. [DOI] [PubMed]
  31. Vagin, A. & Teplyakov, A. (2010). Acta Cryst. D66, 22–25. [DOI] [PubMed]
  32. Vaguine, A. A., Richelle, J. & Wodak, S. J. (1999). Acta Cryst. D55, 191–205. [DOI] [PubMed]
  33. Weiss, M. S. (2001). J. Appl. Cryst. 34, 130–135.
  34. Winn, M. D. et al. (2011). Acta Cryst. D67, 235–242.
  35. Winsor, G. L., Lam, D. K. W., Fleming, L., Lo, R., Whiteside, M. D., Yu, N. Y., Hancock, R. E. W. & Brinkman, F. S. L. (2010). Nucleic Acids Res. 39, D596–D600. [DOI] [PMC free article] [PubMed]
  36. Xiao, G., Déziel, E., He, J., Lépine, F., Lesic, B., Castonguay, M. H., Milot, S., Tampakaki, A. P., Stachel, S. E. & Rahme, L. G. (2006). Mol. Microbiol. 62, 1689–1699. [DOI] [PubMed]
  37. Yu, S., Jensen, V., Seeliger, J., Feldmann, I., Weber, S., Schleicher, E., Häussler, S. & Blankenfeldt, W. (2009). Biochemistry, 48, 10298–10307. [DOI] [PubMed]
  38. Zhou, X., Lou, Z., Fu, S., Yang, A., Shen, H., Li, Z., Feng, Y., Bartlam, M., Wang, H. & Rao, Z. (2010). J. Mol. Biol. 396, 1012–1024. [DOI] [PubMed]

Articles from Acta Crystallographica Section F: Structural Biology and Crystallization Communications are provided here courtesy of International Union of Crystallography

RESOURCES